Searched for
VAMSI KRISHNA BANDI
Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
Hetero to invest Rs 1,000 crore in AP over two years to expand pharma business"We are committed to Andhra Pradesh and will continue to expand our presence here. We'll be investing about Rs 1,000 crore in Andhra Prades...
Hetero gets WHO prequalification for generic Covid antiviral PaxlovidThis is the first WHO prequalification for Paxlovid - a combination of nirmatrelvir and ritonavir which is recommended for treating mild an...
Johnson & Johnson sells its largest India plant as demand weakensJ&J's manufacturing plant spread across 55.27 acres was completed in 2016 to make consumer health products, including babycare range, beaut...
Hetero acquires Johnson & Johnson's manufacturing plant in Telangana"We are committed to an investment upwards of USD 75 million, (approximately Rs 600 crore) to upgrade and enhance existing facilities at th...
More companies in talks for Remdesivir licenceThis week, Cipla, Jubilant Life Sciences, Hetero and Mylan signed non-exclusive licensing agreements for the antiviral drug which received ...
‘We will ensure Remdesivir supply when India wants it’Hyderabad based generic pharmaceutical company Hetero Labs is working on a “war footing” to make remdesivir available for Covid-19 patients...